Triton Market Research presents their Global Infertility testing and treatment report segmented by male infertility testing and treatment, female infertility testing and treatment, end-users (fertility and surgical centers, hospitals and research laboratories, cryobanks) and by geographical region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) - discussing Industry Value Chain Analysis, Porter's 5 Force Analysis, Drivers, Restraints, Vendor Profiles, Global Market Size, Forecasts & Analysis (2019-2027).
Infertility is the inability of a person, animal or plant to reproduce by natural means. The causes of male and female infertility differ. For instance, male infertility can be a result of poor lifestyle choices, sperm abnormality or any environmental factors. On the other hand, female infertility can be a result of damaged fallopian tubes or any ovulation disorders. Owing to factors like increasing rate of male infertility, the popularity of surrogacy technique among couples and increasing fertility tourism in the world, Triton Market Research expects the global infertility testing and treatment market to witness a compound annual growth rate of 6.64% during the forecasted period 2019-2027.
Hospitals are the biggest end-users of this market. Hospitals provide services such as Assisted Reproductive Technology (ART) and non-ART services like semen analysis, structural assay (SCSA) testing, sperm chromatin etc. to infertile couples. However, the cryobanks segment is likely to rise with the fastest CAGR by the end of the forecast period. Cryobanks offer human sperm and semen storage at a sustainable temperature below freezing point.
At present, Europe is the most popular destination in the global infertility testing and treatment market. About 40% of the world’s IVF (invitro-fertilization) clinics are in Europe. The Czech Republic has become a popular destination for couples seeking infertility treatment at lower costs. Other popular markets in this region are UK, Germany, France, and Nordics. Seeing the market flourishment in this region, many global companies are now investing in the Europe infertility testing and treatment market. For instance, Genea Biomedx recently opened its facility in Europe. In vitro fertilization is the most commonly used technique for infertility treatments in this region. However, a decrease in domestic supply and stringent government regulations in Europe are diverting medical tourism to emerging economies like Malaysia, Thailand, India, Singapore, Brazil, etc.
The lower cost and increased awareness levels are one of the key reasons for the effective and widespread adoption of infertility treatments. Global market companies are increasingly targeting the upper-middle-income group because of the increased level of awareness about infertility treatment options amongst them. Major market companies that are trying to establish their presence in this market are Irvine scientific, Ovascience, Progyny, Halotech DNA, Merck, Ferring Pharmaceuticals, Endo Pharmaceuticals, Andrology solutions, Origio, and Genea.
The Global Wood Based Panel Market is estimated to witness growth with a CAGR of 6..
The Global Sport Utility Vehicle (SUV) Market is estimated to grow with a CAGR of ..
The global market for cosmetic bioactive ingredients is expected to advance at a C..